Facing Biotech Foods Without the Fear Factor “Almost everywhere food is sold these days, you are likely to find products claiming to contain no genetically modified substances. But unless you are buying wild mushrooms, game, berries or fish, that statement is untrue.”
Big Changes for Big Pharma Fallout from Vioxx and Celebrex will create plenty of pain in the sector. Here are six trends that will alter the industry in 2005
Biotechs forced to work harder to fill openings: Bay Area biotech companies are scrambling to attract and retain both researchers and executives in a cut-throat national and even international job market.
Merck Outlines Vioxx Defense At its annual meeting, Merck discussed its planned defense against the flood of lawsuits brought on by the withdrawal of Vioxx, an arthritis pill taken at one time or another by 20 million Americans.
Survey Shows Lack of Confidence at FDA About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency’s monitoring of the safety of prescription drugs now being sold, according to an FDA internal survey.
Bill Aims to Protect Joint Patents Patents that result from collaboration between universities and companies won new protections from legal challenge under legislation that passed Congress over the weekend.
Trouble for California Cloning? The United Nations will likely decide Friday, after many delays, whether to vote on an international cloning ban, vote on a new declaration introduced by Italy or delay voting once again. Just weeks after Californians voted for a $3 billion proposition to fund embryonic stem-cell research, which would include therapeutic cloning, […]
The Murky History of Merck’s Vioxx Merck’s decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent medical studies. Here are some key dates in the Vioxx saga:
Contingency Plans Help Current Merck Crisis : In the wake of Merck & Co.’s announcement to pull Vioxx off the market, the pharmaceutical giant pressed forward with plans to launch new products … The fact that companies such as Merck & Co. can quickly bounce back from troublesome corporate crises is a testament to their […]
Reviewing Drug Safety “The Food & Drug Administration has announced a major review of its system for monitoring the safety of drugs already on the market. FDA will sponsor an Institute of Medicine study of the agency’s safety monitoring procedures, and it will set up a formal program to make sure that the views of […]